{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:25:34Z","timestamp":1791599134411,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejmech.2023.115337","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T11:35:02Z","timestamp":1680780902000},"page":"115337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Phenothiazines as anti-cancer agents: SAR overview and synthetic strategies"],"prefix":"10.1016","volume":"254","author":[{"given":"Arun","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Vigato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-3163","authenticated-orcid":false,"given":"Marco Lucio","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2241-0054","authenticated-orcid":false,"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115337_bib1","author":"Ferlay"},{"key":"10.1016\/j.ejmech.2023.115337_bib2","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2023.115337_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/molecules27010276","article-title":"Development of phenothiazine hybrids with potential medicinal interest: a review","volume":"27","author":"Posso","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115337_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1134\/S2079978019020018","article-title":"Recent progress in synthesis, structure and biological activities of phenothiazine derivatives","volume":"9","author":"Gopi","year":"2019","journal-title":"Rev. J. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6709828","article-title":"Targeting lung cancer stem cells with antipsychological drug thioridazine","author":"Yue","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2023.115337_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics6010003","article-title":"Thioridazine: a non-antibiotic drug highly effective, in combination with first line anti-tuberculosis drugs, against any form of antibiotic resistance of Mycobacterium tuberculosis due to its multi-mechanisms of action","volume":"6","author":"Amaral","year":"2017","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2023.115337_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1734-1140(10)70272-3","article-title":"Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank","volume":"62","author":"Pluta","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2023.115337_bib8","first-page":"2533","article-title":"Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds","volume":"15","author":"Sakagami","year":"1995","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2023.115337_bib9","first-page":"5983","article-title":"Possible biological and clinical applications of phenothiazines","volume":"37","author":"Varga","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2023.115337_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopha.2018.06.170","article-title":"Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo\/Dx in the presence of newly synthesized phenothiazine derivatives","volume":"106","author":"\u015aroda-Pomianek","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2023.115337_bib11","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/jhet.3980","article-title":"Synthesis, spectral characterization and antitumor activity of phenothiazine derivatives","volume":"57","author":"Venkatesan","year":"2020","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib12","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1002\/slct.201903203","article-title":"Design, synthesis and characterisation of novel phenothiazine-based triazolopyridine derivatives: evaluation of anti-breast cancer activity on human breast carcinoma","volume":"4","author":"Sachdeva","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2023.115337_bib13","series-title":"Ullmann's Encycl. Ind. Chem","article-title":"Azine dies","author":"Berneth","year":"2008"},{"key":"10.1016\/j.ejmech.2023.115337_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/cr60171a003","article-title":"The chemistry of phenothiazine","volume":"54","author":"Massie","year":"1954","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.115337_bib15","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.1039\/D1TC00695A","article-title":"Recent development on the synthesis, properties and applications of luminescent oxidized phenothiazine derivatives","volume":"9","author":"Rout","year":"2021","journal-title":"J. Mater. Chem. C"},{"key":"10.1016\/j.ejmech.2023.115337_bib16","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1039\/C9NJ03394G","article-title":"Phenothiazine and amide-ornamented dihydropyridines via a molecular hybridization approach: design, synthesis, biological evaluation and molecular docking studies","volume":"43","author":"Sivaramakarthikeyan","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib17","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1007\/s00044-018-2242-5","article-title":"Cytotoxicity, apoptosis, and QSAR studies of phenothiazine derived methoxylated chalcones as anticancer drug candidates","volume":"27","author":"Gul","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115337_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25194566","article-title":"Synthesis of novel chalcone-based phenothiazine derivatives as antioxidant and anticancer agents","volume":"25","author":"Al Zahrani","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115337_bib19","series-title":"Adv Heterocycl Chem","first-page":"273","article-title":"Hydroxyazoles as acid isosteres and their drug design applications\u2014Part 2: bicyclic systems","author":"Pippione","year":"2021"},{"key":"10.1016\/j.ejmech.2023.115337_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11164-018-3594-7","article-title":"Microwave-assisted and thermal synthesis of nanosized thiazolyl-phenothiazine derivatives and their biological activities","volume":"45","author":"Alsharekh","year":"2019","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2023.115337_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.matpr.2020.11.979","article-title":"Design, synthesis, characterization and biological evaluation of some 2-(E)-(N-(azobenzyl)-4-iminoethan-1-yl)-10H-phenothiazines","volume":"42","author":"Shanmugam","year":"2020","journal-title":"Mater. Today Proc."},{"key":"10.1016\/j.ejmech.2023.115337_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10858-021-00371-z","article-title":"Antipsychotic phenothiazine drugs bind to KRAS in vitro","volume":"75","author":"Wang","year":"2021","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.ejmech.2023.115337_bib23","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.2174\/0929867328666210405120330","article-title":"Recent advances in the medicinal chemistry of phenothiazines, new anticancer and antiprotozoal agents","volume":"28","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib24","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1039\/C9NJ01912J","article-title":"Hydrazide-integrated carbazoles: synthesis, computational, anticancer and molecular docking studies","volume":"43","author":"Krishnan","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib25","doi-asserted-by":"crossref","first-page":"13418","DOI":"10.1039\/C9NJ02170A","article-title":"Novel acrylamide\/acrylonitrile-tethered carbazoles: synthesis, structural, biological, and density functional theory studies","volume":"43","author":"Padmavathy","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib26","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1002\/slct.201800748","article-title":"Synthesis, antioxidant evaluation, density functional theory study of dihydropyrimidine festooned phenothiazines","volume":"3","author":"Padmavathy","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2023.115337_bib27","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1039\/C9NJ05489H","article-title":"Phenothiazine and amide-ornamented novel nitrogen heterocyclic hybrids: synthesis, biological and molecular docking studies","volume":"44","author":"Sivaramakarthikeyan","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jat.4046","article-title":"In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review","volume":"41","author":"Otr\u0119ba","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.ejmech.2023.115337_bib29","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1134\/S1070363218110269","article-title":"Synthesis and anticancer evaluation of some phenothiazine derivatives","volume":"88","author":"Ahmed","year":"2018","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2010.06.069","article-title":"8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1","volume":"644","author":"Weso\u0142owska","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115337_bib31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/ijms20040955","article-title":"The combined use of phenothiazines and statins strongly affects doxorubicin-resistance, apoptosis, and cox-2 activity in colon cancer cells","volume":"20","author":"\u015aroda-Pomianek","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115337_bib32","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.2174\/1389450117666160201110449","article-title":"Biophysical screening for identifying pharmacological chaperones and inhibitors against conformational and infectious diseases","volume":"17","author":"Velazquez-Campoy","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2023.115337_bib33","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1172\/JCI127223","article-title":"Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis","volume":"129","author":"Santofimia-Casta\u00f1o","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2023.115337_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111692","article-title":"Design, synthesis and evaluation of novel phenothiazine derivatives as inhibitors of breast cancer stem cells","volume":"183","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3998\/ark.5550190.0007.722","article-title":"Use of the furoxan (1,2,5-oxadiazole 2-oxide) system in the design of new NO-donor antioxidant hybrids","author":"Cena","year":"2006","journal-title":"ARKIVOC (Gainesville, FL, U. S.)"},{"key":"10.1016\/j.ejmech.2023.115337_bib36","series-title":"Adv Heterocycl Chem","first-page":"185","article-title":"Hydroxyazoles as acid isosteres and their drug design applications\u2014Part 1: monocyclic systems","author":"Sainas","year":"2021"},{"key":"10.1016\/j.ejmech.2023.115337_bib37","first-page":"1750","article-title":"Studies on agents with mixed NO-dependent vasodilating and \u03b2-blocking activities, Stud. Agents Mix. NO-Depend","volume":"14","author":"Boschi","year":"1997","journal-title":"Vasodilating \u0392-Blocking Act."},{"key":"10.1016\/j.ejmech.2023.115337_bib38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10637-018-0682-x","article-title":"Antitumor evaluation of novel phenothiazine derivatives that inhibit migration and tubulin polymerization against gastric cancer MGC-803 cells","volume":"37","author":"Liu","year":"2019","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2023.115337_bib39","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1039\/C6MD00169F","article-title":"Design, synthesis and antiproliferative activity studies of 1,2,3-triazole\u2013chalcones","volume":"7","author":"Fu","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2023.115337_bib40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/molecules21050653","article-title":"Design, synthesis and structure-activity relationships of novel chalcone-1,2,3-triazole-azole derivates as antiproliferative agents","volume":"21","author":"Zhang","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115337_bib41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3184\/174751917X15122516000140","article-title":"Design, synthesis and antiproliferative activity of novel phenothiazine-1,2,3-triazole analogues","volume":"41","author":"Ma","year":"2017","journal-title":"J. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115337_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1021\/acsmedchemlett.8b00484","article-title":"Bioisosteres of indomethacin as inhibitors of aldo-keto reductase 1C3","volume":"10","author":"Lolli","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115337_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114366","article-title":"New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold","volume":"237","author":"Pippione","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/cells11020263","article-title":"Tackling the behavior of cancer cells: molecular bases for repurposing antipsychotic drugs in the treatment of glioblastoma","volume":"11","author":"Persico","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2023.115337_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10495-020-01594-5","article-title":"Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma","volume":"25","author":"Omoruyi","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2023.115337_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127037","article-title":"Novel cyanoacetamide integrated phenothiazines: synthesis, characterization, computational studies and in vitro antioxidant and anticancer evaluations","volume":"1199","author":"Krishnan","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2023.115337_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1570180816666181115112236","article-title":"The design and synthesis of novel phenothiazine derivatives as potential cytotoxic agents","volume":"17","author":"Luan","year":"2018","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2023.115337_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.25135\/acg.oc.86.20.10.1853","article-title":"Facile microwave synthesis of a novel phenothiazine derivative and its cytotoxic activity","volume":"13","author":"Andac","year":"2020","journal-title":"Org. Commun."},{"key":"10.1016\/j.ejmech.2023.115337_bib49","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.21873\/anticanres.14495","article-title":"Phenothiazines and selenocompounds: a potential novel combination therapy of multidrug resistant cancer","volume":"40","author":"Gajd\u00e1cs","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2023.115337_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11164-020-04297-3","article-title":"A novel method for the synthesis and characterization of 10-hexyl-3-(1-hexyl-4, 5-diphenyl-1H-imidazole-2-yl)-10H-phenothiazine: DFT computational, in vitro anticancer and in silico molecular docking studies","volume":"47","author":"Ahamed","year":"2021","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2023.115337_bib51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jare.2021.07.003","article-title":"Pegylation of phenothiazine \u2013 a synthetic route towards potent anticancer drugs","volume":"37","author":"Cibotaru","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2023.115337_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111216","article-title":"Water soluble PEGylated phenothiazines as valuable building blocks for bio-materials","volume":"116","author":"Cibotaru","year":"2020","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.ejmech.2023.115337_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18071365","article-title":"Novel thiazolo[5,4-b]phenothiazine derivatives: synthesis, structural characterization, and in vitro evaluation of antiproliferative activity against human leukaemia","volume":"18","author":"Brem","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115337_bib54","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ardp.201100355","article-title":"Heterocycles 27. Microwave assisted synthesis and antitumour activity of novel phenothiazinyl-thiazolyl-hydrazine derivatives","volume":"345","author":"Ignat","year":"2012","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2023.115337_bib55","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/cancers13051003","article-title":"The synergism between DHODH inhibitors and dipyridamole leads to metabolic lethality in acute myeloid leukemia","volume":"13","author":"Gaidano","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2023.115337_bib56","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1021\/acs.jmedchem.0c01549","article-title":"Targeting acute myelogenous leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2-hydroxypyrazolo[1,5- a ]pyridine scaffold: SAR of the biphenyl moiety","volume":"64","author":"Sainas","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jhet.42","article-title":"Synthesis and properties of diaza-, triaza-, and tetraazaphenothiazines","volume":"46","author":"Pluta","year":"2009","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ardp.200900253","article-title":"Antioxidant activity of newly synthesized 2,7-diazaphenothiazines","volume":"343","author":"Morak-M\u0142odawska","year":"2010","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2023.115337_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1734-1140(10)70272-3","article-title":"Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank","volume":"62","author":"Pluta","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2023.115337_bib60","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3109\/14756366.2015.1101092","article-title":"Synthesis and anticancer and lipophilic properties of 10-dialkylaminobutynyl derivatives of 1,8- and 2,7-diazaphenothiazines","volume":"31","author":"Morak-M\u0142odawska","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib61","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3109\/14756366.2016.1151014","article-title":"3,6-Diazaphenothiazines as potential lead molecules \u2013 synthesis, characterization and anticancer activity","volume":"31","author":"Morak-M\u0142odawska","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24020267","article-title":"Synthesis, anticancer activity, and apoptosis induction of novel 3,6-diazaphenothiazines","volume":"24","author":"Morak-M\u0142odawska","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115337_bib63","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1080\/14756366.2019.1639695","article-title":"10H-1,9-diazaphenothiazine and its 10-derivatives: synthesis, characterisation and biological evaluation as potential anticancer agents","volume":"34","author":"Morak-M\u0142odawska","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115337_bib64","first-page":"1","article-title":"Design, synthesis, and structural characterization of novel diazaphenothiazines with 1,2,3-triazole substituents as promising antiproliferative agents","volume":"24","author":"Morak-M\u0142odawska","year":"2019","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.ejmech.2023.115337_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/life11030206","article-title":"Phenothiazines modified with the pyridine ring as promising anticancer agents","volume":"11","author":"Morak-M\u0142odawska","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.ejmech.2023.115337_bib66","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/acs.jmedchem.8b01090","article-title":"Synthesis and biological investigation of phenothiazine-based benzhydroxamic acids as selective histone deacetylase 6 inhibitors","volume":"62","author":"V\u00f6gerl","year":"2019","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423003033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423003033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:51:12Z","timestamp":1759330272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":66,"alternative-id":["S0223523423003033"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115337","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenothiazines as anti-cancer agents: SAR overview and synthetic strategies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115337"}}